Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge

Virology

Volumn 362, Issue 1, 2007, Pages 139-150

  Tompkins, S Mark ^a   Lin, Yuan ^b   Leser, George P ^c   Kramer, Kari A ^a   Haas, Debra L ^a   Howerth, Elizabeth W ^a   Xu, Jie ^b   Kennett, Mary J ^b   Durbin, Russell K ^d   Durbin, Joan E ^d   Tripp, Ralph ^a   Lamb, Robert A ^c   He, Biao ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Influenza virus; Parainfluenza virus 5; Vaccine; Viral vector

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; HEMAGGLUTININ; LIVE VACCINE; SIALIDASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 5; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN PARAINFLUENZA VIRUS 5; VACCINE PRODUCTION; VERO CELL; VIRION; VIRUS IMMUNITY; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; CATTLE; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SIMIAN VIRUS 5; VACCINES, SYNTHETIC;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE; PARAINFLUENZA VIRUS; RNA VIRUSES; SIMIAN VIRUS 5;

EID: 34247252472     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.12.005     Document Type: Article

References (51)

1. Arimilli S., Alexander-Miller M.A., and Parks G.D. A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function. J. Virol. 80 (2006) 3416-3427
2. Atoynatan T., and Hsiung G.D. Epidemiologic studies of latent virus infections in captive monkeys and baboons: II. Serologic evidence of myxovirus infections with special reference to SV5. Am. J. Epidemiol. 89 (1969) 472-479
3. Azetaka M., and Konishi S. Kennel cough complex: confirmation and analysis of the outbreak in Japan. Nippon Juigaku Zasshi 50 (1988) 851-858
4. Binn L.N., Eddy G.A., Lazar E.C., Helms J., and Murnane T. Viruses recovered from laboratory dogs with respiratory disease. Proc. Soc. Exp. Biol. Med. 126 (1967) 140-145
5. Bukreyev A., Huang Z., Yang L., Elankumaran S., St. Claire M., Murphy B.R., Samal S.K., and Collins P.L. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J. Virol. 79 (2005) 13275-13284
6. Chatziandreou N., Stock N., Young D., Andrejeva J., Hagmaier K., McGeoch D.J., and Randall R.E. Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J. Gen. Virol. 85 (2004) 3007-3016
7. Choppin P.W. Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology 23 (1964) 224-233
8. Cohn M.L., Robinson E.D., Thomas D., Faerber M., Carey S., Sawyer R., Goswami K.K., Johnson A.H., and Richert J.R. T cell responses to the paramyxovirus simian virus 5: studies in multiple sclerosis and normal populations. Pathobiology 64 (1996) 131-135
9. Cornwell H.J., McCandlish I.A., Thompson H., Laird H.M., and Wright N.G. Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet. Rec. 98 (1976) 301-302
10. Didcock L., Young D.F., Goodbourn S., and Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73 (1999) 9928-9933
11. Epstein S.L. Control of influenza virus infection by immunity to conserved viral features. Expert Rev. Anti Infect. Ther. 1 (2003) 627-638
12. He B., and Lamb R.A. Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses. J. Virol. 73 (1999) 6228-6234
13. He B., Paterson R.G., Ward C.D., and Lamb R.A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237 (1997) 249-260
14. He B., Paterson R.G., Stock N., Durbin J.E., Durbin R.K., Goodbourn S., Randall R.E., and Lamb R.A. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303 (2002) 15-32
15. Hsiung G.D. Parainfluenza-5 virus. Infection of man and animal. Prog. Med. Virol. 14 (1972) 241-274
16. 15. Am. J. Hyg. 63 (1956) 204-215
17. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., and Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227 (1997) 493-499
18. Jin H., Subbarao K., Bagai S., Leser G.P., Murphy B.R., and Lamb R.A. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J. Virol. 70 (1996) 1406-1414
19. Komada H., Klippmark E., Orvell C., Randall R.E., Ito Y., and Norrby E. Immunological relationships between parainfluenza virus type 4 and other paramyxoviruses studied by use of monoclonal antibodies. Arch. Virol. 116 (1991) 277-283
20. Lamb R.A., and Kolakofsky D. Paramyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. (2001), Lippincott, Williams and Wilkins, Philadelphia
21. Lee E.S., Zhou H., and Henderson A.J. Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism. J. Virol. 75 (2001) 9703-9712
22. Lin G.Y., and Lamb R.A. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J. Virol. 74 (2000) 9152-9166
23. Lin Y., Bright A.C., Rothermel T.A., and He B. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 77 (2003) 3371-3383
24. Lin Y., Horvath F., Aligo J.A., Wilson R., and He B. The role of simian virus 5 V protein on viral RNA synthesis. Virology 338 (2005) 270-280
25. McCandlish I.A., Thompson H., Cornwell H.J., and Wright N.G. A study of dogs with kennel cough. Vet. Rec. 102 (1978) 293-301
26. Murphy S.K., and Parks G.D. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology 232 (1997) 145-157
27. Nakaya T., Cros J., Park M.S., Nakaya Y., Zheng H., Sagrera A., Villar E., Garcia-Sastre A., and Palese P. Recombinant Newcastle disease virus as a vaccine vector. J. Virol. 75 (2001) 11868-11873
28. Neumann G., Whitt M.A., and Kawaoka Y. A decade after the generation of a negative-sense RNA virus from cloned cDNA-what have we learned?. J. Gen. Virol. 83 (2002) 2362-2635
29. Palese P., Zheng H., Engelhardt O.G., Pleschka S., and Garcia-Sastre A. Negative-strand RNA viruses: genetic engineering and applications. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11354-11358
30. Park M.S., Steel J., Garcia-Sastre A., Swayne D., and Palese P. From the cover: engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8203-8208
31. Paterson R.G., and Lamb R.A. The molecular biology of influenza viruses and paramyxoviruses. In: Davidson A., and Elliott R.M. (Eds). Molecular Virology: A Practical Approach (1993), IRL Oxford Univ. Press, Oxford 35-73
32. Paterson R.G., Russell C.J., and Lamb R.A. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology 270 (2000) 17-30
33. Pekosz A., He B., and Lamb R.A. Reverse genetics of negative-strand RNA viruses: closing the circle. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8804-8806
34. Peluso R.W., Lamb R.A., and Choppin P.W. Polypeptide synthesis in simian virus 5-infected cells. J. Virol. 23 (1977) 177-187
35. Randall R.E., and Young D.F. Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences. J. Gen. Virol. 69 (1988) 2051-2060
36. Roberts A., and Rose J.K. Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 247 (1998) 1-6
37. Roberts A., Kretzschmar E., Perkins A.S., Forman J., Price R., Buonocore L., Kawaoka Y., and Rose J.K. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72 (1998) 4704-4711
38. Rosenberg F.J., Lief F.S., Todd J.D., and Reif J.S. Studies of canine respiratory viruses: I. Experimental infection of dogs with an SV5-like canine parainfluenza agent. Am. J. Epidemiol. 94 (1971) 147-165
39. Schmitt A.P., He B., and Lamb R.A. Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J. Virol. 73 (1999) 8703-8712
40. Schmitt A.P., Leser G.P., Morita E., Sundquist W.I., and Lamb R.A. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79 5 (2005) 2988-2997
41. Schnell M.J., Mebatsion T., and Conzelmann K.-K. Infectious rabies viruses from cloned cDNA. EMBO J. 13 (1994) 4195-4203
42. Sun M., Rothermel T.A., Shuman L., Aligo J.A., Xu S., Lin Y., Lamb R.A., and He B. Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis. J. Virol. 78 (2004) 5068-5078
43. Tokusumi T., Iida A., Hirata T., Kato A., Nagai Y., and Hasegawa M. Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Res. 86 (2002) 33-38
44. Tribe G.W. An investigation of the incidence, epidemiology and control of Simian virus 5. Br. J. Exp. Pathol. 47 (1966) 472-479
45. Tsurudome M., Nishio M., Komada H., Bando H., and Ito Y. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology 171 (1989) 38-48
46. Vandvik B., and Norrby E. Paramyxovirus SV5 and multiple sclerosis. Nature 338 (1989) 769-771
47. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., Mundt E., Schirrmeier H., Mebatsion T., Mettenleiter T.C., and Romer-Oberdorfer A. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8197-8202
48. Wilson R.L., Fuentes S.M., Wang P., Taddeo E.C., Klatt A., Henderson A.J., and He B. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80 (2006) 1700-1709
49. Young D.F., Randall R.E., Hoyle J.A., and Souberbielle B.E. Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J. Virol. 64 (1990) 5403-5411
50. Yuan P., Thompson T.B., Wurzburg B.A., Paterson R.G., Lamb R.A., and Jardetzky T.S. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13 (2005) 803-815
51. Zakstelskaya L.Y., Zhdanov V.M., Yakhno M.A., Gushchin B.V., Klimenko S.M., Demidova S.A., Konovalova N.G., and Gushchina E.A. Persistent SV5 virus infection in continuous cell cultures. Acta Virol. 20 (1976) 506-511